September 17, 2026

Oxidative stress in refractory and recurrent vitiligo: from immune amplification mechanisms to potential stratified antioxidant combination therapy – Frontiers

September 17, 2026

Rethinking Safety Perceptions Around JAK Inhibitors in Vitiligo – The American Journal of Managed Care

September 17, 2026

Vitiligo developing during dupilumab treatment in a child with atopic dermatitis: a case report and literature review – Frontiers

September 16, 2026

Longer Topical JAK Inhibitor Treatment Linked to Vitiligo Improvement in Real-World Study – Dermatology Times

September 10, 2026

Cross-Trial Vitiligo Data: What Payers Can and Can’t Compare – The American Journal of Managed Care